U.S. Beverage Stock News

In July 2026, Eos Energy Enterprises filed a US$19.9 million shelf registration for 5,000,000 common shares tied to an ESOP offering, completed a US$37.74 million rights-based composite units offering, and reported record preliminary second-quarter revenue alongside new defense and utility-scale storage project milestones for its Z3 battery platform. These moves collectively bolster funding for Frontier Power USA and accelerate deployment of Eos’s American-made, zinc-based long-duration...

Carpenter Technology (CRS) is in focus ahead of its July 30 earnings report, with expectations for year over year growth in earnings and revenue shaping how investors assess the recent share price momentum. See our latest analysis for Carpenter Technology. The recent move in Carpenter Technology’s share price, with a 7 day share price return of 8.23% and a 90 day share price return of 41.22%, comes on top of very large multi year total shareholder returns. This suggests that momentum has been...

Paymentus Holdings stock has delivered a strong 166.1% return over the past three years, yet its current valuation checks point to a share price that screens as expensive rather than as an obvious bargain. Over the past three years, Paymentus Holdings has returned 166.1%, which puts extra focus on whether the current price still reflects a reasonable expectation for the business. For a payments platform reliant on scaling transaction volumes and managing technology costs, expectations for...

Sharplink stock has seen its share price fall very sharply over the past five years, yet today the valuation checks still lean expensive rather than pointing to a clear bargain. Over the last five years, Sharplink’s share price has declined about 99%, which raises questions about how much long term value the current business model can support. Backing for the EthSystems launch may support Sharplink’s role in Ethereum focused privacy solutions. At the same time, execution risk around turning...

In July 2026, DexCom, Inc. received Health Canada authorization for its Dexcom G7 15 Day Continuous Glucose Monitoring System for adults with diabetes, offering up to 15.5 days of wear, best-in-class accuracy with an overall MARD of 8.0%, and multiple app-based connectivity and data-sharing features. This approval not only extends DexCom’s CGM presence in Canada but also underscores how longer wear duration and fewer sensor changes may strengthen its competitive position in digitally...

Coca-Cola stock has delivered a 67.2% total return over the past 5 years, yet there is a clear split between what its intrinsic value estimate suggests and what traditional market multiples imply, with the Discounted Cash Flow (DCF) pointing to some undervaluation while earnings based ratios look rich. A 67.2% return over 5 years puts Coca-Cola in the camp of long term winners, which can compress the margin of safety if cash flows do not keep pace with investor expectations. Recent...

Earlier this year, Analog Devices announced it would release its third-quarter fiscal 2026 results on 19 August 2026, with senior executives hosting a conference call to discuss performance and business outlook. Analysts’ expectations for a very large year-on-year earnings increase, supported by prior strength in industrial, data center, and automotive demand, have drawn attention to ADI’s high-margin, high-cash-flow profile. With analysts expecting strong upcoming quarterly earnings, we’ll...

Morgan Stanley recently reiterated a Hold rating on Ares Management ahead of its late-July Q2 2026 earnings release, while investors also focused on the firm’s lending role in Charterhouse Capital Partners’ acquisition of French emergency building repairs group Batibig. This renewed analyst attention, combined with Ares’ expanding footprint in European private credit, is reshaping how the market views its fee-based growth and risk profile. We’ll now examine how this refreshed analyst...

In July 2026, The Hanover Insurance Group announced that longtime CEO Jack Roche would retire at the end of 2026, with chief operating officer Richard Lavey named CEO-elect and slated to join the board on January 1, 2027, following a brief advisory period for Roche. This planned transition hands the reins to an insider who oversees operations and Hanover Agency Markets, which account for about 75% of the company’s US$7.00 billion in gross premiums written. We’ll now examine how appointing...

Berkshire Hathaway has completed its acquisition of Taylor Morrison Home, previously listed as NYSE:TMHC. The transaction converts Taylor Morrison Home into a privately held company while keeping its existing management team in place. The company is expected to undergo board and governance changes under the oversight of Berkshire Hathaway. Taylor Morrison stock, which last closed at $72.45, will no longer trade on public exchanges or be included in equity indices. Taylor Morrison Home,...

Williams-Sonoma (WSM) is back in focus as investors look ahead to the company’s upcoming quarterly earnings report, with recent stock moves shaped by its history of outperforming earnings expectations and cautiously positive analyst sentiment. See our latest analysis for Williams-Sonoma. At a share price of $226.74, Williams-Sonoma has seen a 3.72% 1 day share price gain, while its 90 day share price return of 18.99% and 1 year total shareholder return of 26.54% point to momentum that has...

Cullen/Frost Bankers has delivered a 77.5% total return over the past five years, yet its valuation checks send mixed signals, with an intrinsic value estimate from the Excess Returns model suggesting the stock trades at a discount while traditional market multiples lean the other way. A 77.5% five year return can make Cullen/Frost Bankers look like a long term winner, but it also raises the bar for what counts as good value today. Expectation of further earnings strength may support the...

Akso Health Group has released its full-year results for the period ended March 31, 2026, reporting sales of US$13.84 million and revenue of US$13.83 million, alongside a net loss of US$18.67 million. While top-line figures were slightly lower than the prior year, the loss per share narrowed to US$0.03, pointing to significantly improved cost control or operational efficiency. We’ll now examine how this sharp reduction in net loss shapes Akso Health Group’s investment narrative and what it...

Cleveland-Cliffs (CLF) has just posted Q2 2026 results with revenue of US$5.2 billion and a basic EPS loss of US$0.25, while net income excluding extra items came in at a loss of US$143 million. The company has seen quarterly revenue move from US$4.3 billion in Q4 2025 to US$4.9 billion in Q1 2026 and US$5.2 billion in Q2 2026, as quarterly basic EPS loss narrowed from US$0.44 in Q4 2025 to US$0.41 in Q1 2026 and US$0.25 in Q2 2026. This sets up an earnings season in which investors are...

Somnigroup International (SGI) recently completed its rebranding from Tempur Sealy International, a shift that puts fresh attention on how the stock’s current valuation lines up with its fundamentals and recent share price performance. See our latest analysis for Somnigroup International. Somnigroup International’s share price has eased over recent months, with a share price return of down 6.48% over 30 days and down 19.36% year to date. Its 5 year total shareholder return of 74.15% points to...

Earlier this month, Intuitive Surgical filed a US$1.77 billion shelf registration for 5,000,000 common shares linked to its employee stock ownership plan, alongside reporting second-quarter 2026 revenue of US$2,892.3 million and net income of US$818.1 million, both higher than a year ago. At the same time, Intuitive outlined a five-layer AI framework and live telesurgical collaboration, underscoring efforts to embed intelligence across its robotic ecosystem. Next, we’ll explore how...

Lockheed Martin stock has climbed 79.4% over the past five years, yet Simply Wall St's valuation work suggests the shares may still trade below intrinsic value. Both the Discounted Cash Flow (DCF) estimate and market multiples point to an undervalued setup rather than an overly stretched one. Over the last five years, a 79.4% total return indicates investors have already priced in a lot of good news. The key question is whether the current level still leaves a margin between price and...

Abbott Laboratories (ABT) is back on investors’ radar after second quarter 2026 earnings showed higher year over year sales alongside lower net income and earnings per share, refocusing attention on future growth drivers. See our latest analysis for Abbott Laboratories. The latest earnings release appears to have reset expectations for Abbott Laboratories, with the share price up 13.9% over 30 days and 13.1% over 90 days, even as the year to date share price return and one year total...

Earlier this week, Main Street Capital drew attention as investors looked ahead to its now-upcoming August 6, 2026 earnings report and fresh profit and revenue expectations. The discussion has increasingly centered on how any shift in supplemental dividends and credit conditions could reshape the company’s income profile and perceived value. We’ll now examine how concerns over supplemental dividend sustainability may influence Main Street Capital’s broader investment narrative and...

Customers Bancorp (CUBI) is back in focus after reporting Q2 2026 results, with net interest income of $193.37 million and net income of $71.56 million, alongside a completed share repurchase tranche. See our latest analysis for Customers Bancorp. At a latest share price of $76.52, Customers Bancorp has seen short term share price weakness, with a 30 day share price return down 2.70%, while the 1 year total shareholder return of 24.04% and 3 year total shareholder return of 83.11% point to...

Moog (MOG.A) recently drew renewed attention after analysts highlighted its history of earnings surprises, a positive Earnings ESP, and confirmation of full-year net sales guidance of about US$4.30 billion ahead of its 31 July 2026 results. This combination of upbeat earnings sentiment, focus on execution, margins and cash generation, and favorable growth scoring has sharpened investor interest in how resilient Moog’s profit trajectory may be. We’ll now examine how this upbeat earnings...

Chevron stock has delivered a strong 5 year run, yet today its valuation picture is split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to a sizable upside while market based multiples suggest the shares are on the expensive side. Chevron has returned 134.9% over the past 5 years, which puts extra focus on whether current buyers are paying too much for past gains. Partnerships such as the GE Vernova joint venture for natural gas powered AI data centers can support long...

The latest FDA advisory panel vote on broader peptide compounding access, including BPC-157 and related compounds, has pushed Hims & Hers Health (HIMS) back into focus for investors watching regulatory catalysts. See our latest analysis for Hims & Hers Health. For context, Hims & Hers Health’s recent FDA catalyst comes after a period where the share price has fallen 14.1% over the past 30 days and 15.9% year to date, while the 1 year total shareholder return is down 51.3% and the 3 year total...

Earlier this week, General Dynamics European Land Systems announced it had selected Allison Transmission Holdings to supply fully automatic transmissions for about 3,000 EAGLE V armored vehicles, with an option for roughly 2,000 additional units. This defense contract underscores Allison’s growing exposure to higher-margin, specialized vehicle applications at a time when its traditional highway markets face softness and electrification risks. We’ll now examine how this new armored-vehicle...